Additional lab facility and federal licence application add expanded contract services to portfolio VANCOUVER, BC, Oct. 8, 2021 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a leader in psychedelics-focused mental healthcare, is pleased to announce the expansion of its psychedelics research facility with an additional lab and application for federal licensing…


Previous articlePT266 – Jerry B. Brown, Ph.D. – Psychedelics: Past, Present, and Future
Next articleMindset Pharma Expands Benchmarking Data for First Generation Psychedelics Through the COPE Program with InterVivo Solutions